Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Bascome

Optometrist Ft Lauderdale, FL Doctor of Optometry

NPI 1184927105 CMS profile 1080325

2502 E Oakland Park Blvd, Ft Lauderdale, FL 33306

Open in the dashboard

General payments

$20,687

117 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Bascome of Ft Lauderdale, FL is reported in the CMS Open Payments database as having received $20,687 across 117 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,333 11
2024 General $289 8
2023 General $1,073 21
2022 General $1,199 25
2021 General $437 14
2020 General $2,367 8
2019 General $1,990 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Bascome
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to John Bascome were reported at $13,333. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year John Bascome Optometrist median Middle half National median
2019 $1,990 $159 $67–$371 $163
2020 $2,367 $72 $29–$165 $114
2021 $437 $125 $46–$292 $132
2022 $1,199 $162 $66–$374 $149
2023 $1,073 $177 $72–$406 $160
2024 $289 $188 $77–$427 $164
2025 $13,333 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Visionary Optics LLC $11,445 1 payment
  2. Johnson & Johnson Vision Care, Inc. $2,210 49 payments
  3. OCULUS, Inc. $2,140 1 payment
  4. CooperVision Inc. $2,097 18 payments
  5. Bausch & Lomb, a division of Bausch Health US, LLC $1,754 21 payments
  6. Glaukos Corporation $178 4 payments
  7. Johnson & Johnson Surgical Vision, Inc. $145 1 payment
  8. Shire North American Group Inc $140 2 payments
  9. Optos, Inc. $108 2 payments
  10. New World Medical,Inc. $84 1 payment
  11. Other $385 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Gift $11,445 1 payment
  2. Food and Beverage $4,054 100 payments
  3. Honoraria $2,140 1 payment
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,500 1 payment
  5. Travel and Lodging $1,150 9 payments
  6. Consulting Fee $290 3 payments
  7. Entertainment $108 2 payments
Products named General payments · program years 2019–2025
  1. OCULUS Keratograph 5M $2,140 1 payment
  2. Acuvue $1,952 42 payments
  3. Onefit Contact Lens $1,685 5 payments
  4. ULTRA $1,559 15 payments
  5. BIOTRUE $1,400 11 payments
  6. BIOTRUE ONE DAY $543 9 payments
  7. MyDay Contact Lens $196 4 payments
  8. LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE) $145 1 payment
  9. XIIDRA $140 2 payments
  10. KXL System $117 2 payments
  11. Other $1,267 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$18,802

Medicare's payments for the services billed

Medicare patients

117

Average age 74

Services billed

256

57 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 50%
Ischemic heart disease 31%
Diabetes 21%
Cancer 19%
Osteoporosis 19%
Chronic kidney disease 18%
Depression 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

117 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record